Often in writing applications there is a tendency to denigrate prior art techniques. This is not risk free as the patentee in Nuvo Pharmaceuticals (Ireland) v. Dr. Reddy's Laboratories, Inc. (Fed. Cir. May 15, 2019) discovered.

James Love wrote an article entitled "Patent Strategy and The Internet of Medical Things," featured in Med Device Online.

Oblon will be sponsoring the LESI 2019 Annual Conference in Yokohama Japan entitled "Create IP Culture – Open for Business," on May 26-28, 2019.

Rob Tarcu at the USPTO Community Day 2019.

Oblon is proud to announce that three partners have been named "IP Stars" by Managing Intellectual Property's magazine. Partners Philippe Signore, Todd Baker, and Alex Hadjis ranked nationally as "IP Stars" in 2019. Alexander Englehart and Chris Ricciuti have been named "Rising Stars" for 2019.

Philippe Signore is quoted in a Law360 article that highlights Oblon's ranking as the Top Patent Firm of 2018, securing the most Utility Patents in 2018. Oblon is proud that this is the fourth consecutive year the firm achieved this top spot on the Harrity patent analytics list.